AAV5 vector for transducing brain cells and lung cells
AssigneesThe United States of America as represented by the Department of Health and Human Services, University of Iowa Research Foundation
InventorsJohn A. Chiorini, Robert M. Kotin, Beverly Davidson, Joseph Zabner
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of delivering nucleic acids to specific regions, tissues and cell types of the CNS. More particularly the invention provides methods of delivering nucleic acids to cells of the CNS such as cerebellar cells and ependymal cells. The invention also provides methods of delivering nucleic acids to cells of the lung such as alveolar cells using AAV5 vectors and particles.
Claims9
A method of delivering a nucleic acid to an alveolar acid cell, in vitro, comprising administering to the alvcolar cell a AAV5 particle containing a vector comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, thereby delivering the nucleic acid to the cell.
A method of delivering a nucleic acid to an alvcolar cell in a subject comprising administering to the subject an AAV5 particle comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, wherein the AAV5 particle is delivered intranasally, thereby delivering the nucleic acid to an alvcolar cell in the subject.
A method of delivering a nucleic acid to an alvcolar cell in a subject comprising administering to the subject an AAV5 particle comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, wherein the AAV5 particle is delivered via aerosol, thereby delivering the nucleic acid to an alvcolar cell in the subject.
A method of delivering a nucleic acid to an alvcolar cell in a subject comprising administering to the subject an AAV5 particle comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, wherein the AAV5 particle is delivered via the airway, thereby delivering the nucleic acid to an alvcolar cell in the subject.
A method of delivering a nucleic acid to a cerebellar cell, in vitro, comprising administering to the cerebellar cell an AAV5 particle containing vector comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, wherein delivering the nucleic acid to the cell.
A method of delivering a nucleic acid to an cerebellar cell in a subject comprising administering to the subject an AAV5 particle comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, wherein the AAV5 particle is delivered directly to the brain of the subject, thereby delivering the nucleic acid to a cerebellar cell in the subject.
A method of delivering a nucleic acid to an ependymal cell, in vitro comprising administering to the ependymal cell an AAV5 particle comprising a vector comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, thereby delivering the nucleic acid to an ependymal cell.
A method of delivering a nucleic acid to an ependymal cell in a subject comprising administering to the subject an AAV5 particle comprising the nucleic acid inserted between a pair of AAV inverted terminal repeats, wherein the AAV5 particle is delivered directly to the brain of the subject, thereby delivering the nucleic acid to an ependymal cell in the subject.
Dependencies are inferred from the claim text.